Objectives. No estimates exist regarding the extent of prescription opioid use among US adults who are the primary caregivers to children.
Introduction
Over the last two decades in the United States, there has been increased use of prescription opioids. Between 2000 and 2009, the number of opioid prescriptions per 100 US residents increased by 35.2%, reaching a rate of almost one opioid prescription per person per year [1] . From 1991 From -2002 From to 2011 From -2012 , the percent of US adults age 20 and older who reported that they had used a prescription opioid in the past 30 days increased from 5.0% to 6.9% [2] .
Accompanying the increased availability and use of prescription opioids has been an associated increase in prescription opioid-related morbidity and mortality. Data V C 2017 American Academy of Pain Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com from the Drug Abuse Warning Network (DAWN) revealed that from 2004 to 2011 nonmedical use of prescription opioids increased by 165% and emergency department visits related to prescription opioids increased by 183% [3, 4] . Between 1999 and 2014, the age-adjusted rate of overdose deaths involving prescription opioids more than tripled [5] . Though the rapid increase in morbidity and mortality associated with prescription opioid use has slowed in recent years [6] , it remains a significant public health concern.
Several nationally representative data sources such as the National Survey on Drug Use and Health (NSDUH), the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), and the National Health and Nutrition Examination Survey (NHANES) provide information on the use of prescription opioids among various populations in the United States. However, an important gap in the literature is that no estimates exist regarding the extent of prescription opioid use among US adults who are the primary caregivers to children. Understanding the extent of prescription opioid use among parents is important as previous studies have documented adverse effects of parental substance use on parenting behaviors. Some research indicates that Substance-abusing parents show less warmth, responsiveness, engagement, sensitivity, and effective discipline than non-substance-abusing parents [7] .
A few studies have documented negative implications of opioid abuse, including abuse of illicit (i.e., heroin) or prescription opioids, for parenting behaviors [8] [9] [10] . Qualitative interviews with self-identified opioid-abusing parents revealed an adverse effect of opioid abuse on the physical and emotional availability of parents and on ability of the parents to provide an emotionally consistent environment for their children [8] . Among a sample of parents receiving treatment at methadone clinics, residential and family disruptions were common over the study's 12-year follow-up period, and children reported low levels of family cohesiveness [9] . In addition, the majority of children (61.6%) reported having experienced three or more childhood adversities, such as emotional, physical, or sexual abuse, witnessing domestic violence, or having a family member incarcerated, in addition to having a substance-abusing parent [9] . In a small study of parents in inpatient treatment for prescription opioid dependence, parents reported substantial negative consequences related to their prescription opioid use, such as having family or money problems, and more than half reported that their prescription opioid use affected their parenting [10] .
Prescription opioid use constitutes a key pathway to abuse given the high abuse potential of these medications and the associated risk of physical and psychological dependence [11] . In addition, use of prescription opioids has been found to be associated with impairments in cognitive and psychomotor functioning, physiological effects such as feeling lightheaded, sluggish, and nauseous, and subjective effects related to the potential for the medication to be abused such as wanting to take more of the medication [12] [13] [14] . Importantly, the average prescription size of opioids, in milligrams per 100 people, has increased since the early 2000s [1] and these effects have been found to be particularly pronounced at higher doses [12] [13] [14] . Even if used as prescribed, prescription opioids have the potential to impair decision-making and parenting behaviors, and use may lead to abuse and dependence.
In light of the recent epidemic of prescription opioid use and previous research regarding potential associations between opioid use and adverse parenting behaviors, it is important to quantify the extent of prescription opioid use among parents and examine associated characteristics and behaviors in order to gain insight into the public health implications of parental prescription opioid use. Thus, the primary aim of the present study was to use a nationally representative sample to compare parents and nonparents with respect to recent prescription opioid use and medical conditions with the potential to precipitate prescription opioid use. The secondary aim was to examine the demographic characteristics and substance use and misuse behaviors among parents with and without recent prescription opioid use. We hypothesized that the percentage of parents and nonparents with recent prescription opioid use and medical conditions that might precipitate use would not differ significantly. We also hypothesized that there would be demographic differences between parents with and without recent prescription opioid use and that a higher percentage of parents with recent prescription opioid use would report substance use and misuse behaviors compared with parents without recent prescription opioid use.
Methods

Data Source
Data were derived from Wave IV of the National Longitudinal Study of Adolescent to Adult Health (Add Health). Add Health is a nationally representative probability sample of 20,745 US adolescents who were in grades 7 through 12 during the 1994-1995 academic year. Follow-up in-home interviews of the sample were conducted in 1996 (Wave II), 2001-2002 (Wave III), and 2008 (Wave IV). At Wave IV, 15,701 young adults (80% response rate) age 24 to 32 years were interviewed. We restricted the analytic sample to Wave IV respondents with valid cross-sectional survey weights (N ¼ 14,800).
Measures
Parents
We defined parents as respondents who reported a biological, step, or adopted child living in the household at the time of the Wave IV interview (N ¼ 6,872). We excluded respondents who reported a biological child who was not living in the household as we were interested in those who were the primary caregivers to children (N ¼ 962). We defined nonparents as respondents who did not report any children living in the household or any biological children living outside of the household (N ¼ 6,966).
Prescription Opioid Use
Data concerning respondents' use of prescription medications in the last four weeks were collected during the Wave IV interview. If the interview was conducted in the respondent's home or medication containers were readily available (e.g., in the respondent's purse), interviewers asked the respondent to present the medications so that the interviewer could record the name of the medication. Otherwise, the respondent was asked to list from memory any prescription medications they had taken in the last four weeks. All medications were therapeutically categorized using Multum Lexicon and assigned a nine-digit therapeutic classification code. Because the reason for medication use was not collected and some medications can be used to treat a variety of conditions, each medication could be assigned up to four separate nine-digit therapeutic classification codes [15] . Consistent with prior research, we categorized prescription medications as prescription opioids if any of the following codes were included in any nine-digit therapeutic classification code corresponding to a single medication: 060 (narcotic analgesics), 191 (narcotic analgesic combinations), or 059 (miscellaneous analgesics) [2] . Nonsteroidal antiinflammatory agents were not included.
Medical Conditions
Medical conditions with the potential to precipitate prescription opioid use included self-report of a lifetime diagnosis of cancer, excluding skin cancer; an injury in the last four weeks; a serious injury in the last 12 months such as a broken bone, cut or laceration, burn, torn muscle, or other injury that interfered with daily tasks; and surgery in the last four weeks.
Demographic Characteristics
Demographic characteristics included respondent sex (male or female), race (white, black, or other), educational level (less than high school, completed high school, some college or trade school, or college or more), age, and experience of financial hardship in the last 12 months (yes or no). Race was based on the interviewer's observation of the respondent's race. Selfreported race was not collected at the Wave IV interview, and Wave III self-reported race was missing for approximately 18% of Wave IV respondents. Education was based on the respondent's self-reported highest level of education received to date. Age was calculated using the month and year of the interview and the month and year of the respondent's birth. Financial hardship in the last 12 months was created as a composite of three questions that assessed respondents' ability to pay for basic needs. We considered respondents to have experienced financial hardship in the last 12 months if they indicated that there was a time in the last 12 months when at least one of the following occurred: they did not pay the full amount of rent or mortgage because they didn't have enough money; they did not pay the full amount of a gas, electricity, or oil bill because they didn't have enough money; or they worried whether food would run out before they got money to buy more.
Prescription Medication Misuse
Prescription medication misuse was measured by asking respondents "Have you ever taken any prescription medications that were not prescribed for you, taken prescription medications in larger amounts than prescribed, more often that prescribed, for longer periods than prescribed, or taken prescription medications only for the feeling or experience they caused?" Respondents were also asked about misuse of specific types of prescription medications including: pain killers or opioids, such as such as Vicodin, OxyContin, Percocet, Demerol, Percodan, or Tylenol with codeine; tranquilizers, such as Librium, Valium, or Xanax; sedatives or downers, such as barbiturates, sleeping pills, Quaalude, or Seconal; and stimulants or uppers, such as amphetamines, prescription diet pills, Ritalin, Preludin, or speed. We categorized respondents according to whether or not they reported having ever having misused prescription medications in general and each type of prescription medication specifically. Responses of "don't know" were treated as missing.
DSM-IV Lifetime Diagnosis of Substance Abuse or Dependence
A lifetime diagnosis of substance abuse or dependence was based on criteria from the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). A DSM-IV lifetime diagnosis of alcohol abuse or dependence was based on the number of DSM-IV alcohol abuse and dependence symptoms each respondent reported, the presence of three or more alcohol dependence symptoms in a single year, and the respondent's report of ever having needed to drink more in order to get the desired effect or difficulties cutting down or quitting drinking. A DSM-IV lifetime diagnosis of marijuana abuse or dependence was based on the number of DSM-IV marijuana abuse and dependence symptoms each respondent reported, the presence of three or more marijuana dependence symptoms in a single year, and the respondent's report of ever having needed to use more marijuana than usual in order to get the desired effect or marijuana withdrawal symptoms such as cravings, feeling depressed, anxious, restless or irritable, having trouble concentrating, feeling tired or weak, having trouble sleeping, or having a change in appetite during the first few hours of not using marijuana. A DSM-IV lifetime diagnosis of other drug abuse or dependence was based on the number of DSM-IV other drug abuse and dependence symptoms reported, the presence of three or more other drug dependence symptoms in a single year, and the respondent's report of ever having needed to use more of a drug in order to get the desired effect or ever experiencing difficulties cutting down or quitting the drug. Other drug questions were asked in reference to the drug, other than marijuana, that the respondents reported having used most frequently in their lifetime.
Statistical Analysis
We conducted chi-square tests to compare the prevalence of recent prescription opioid use and medical conditions with the potential to precipitate prescription opioid use (i.e. having taken a prescription opioid in the last four weeks) among parents and nonparents. We also conducted chi-square tests to compare the prevalence of demographic characteristics, prescription drug misuse, and DMS-IV lifetime diagnoses of substance abuse or dependence among parents with and without recent prescription opioid use. Analyses were conducted in SAS 9.4 (SAS Institute, Inc., Cary, NC, USA). Sampling weights were applied to all analyses to account for the complex sampling design of Add Health. Add Health procedures were approved by the Institutional Review Board at the University of North Carolina at Chapel Hill. The present analyses were considered exempt.
Results
Prescription Opioid Use
A significantly higher percentage of parents (6.7%) compared with nonparents (3.9%) had taken a prescription opioid in the last four weeks (Table 1) .
Medical Conditions
Medical conditions with the potential to precipitate prescription opioid use are shown in Table 2 . Parents and nonparents were similar with respect to the percentage that reported a lifetime cancer diagnosis and surgery in the last four weeks. A significantly lower percentage of parents compared with nonparents reported an injury in the last four weeks (2.8% vs 4.0%) or a serious injury in the last 12 months (11.9% vs 14.0%).
Demographic Characteristics
Demographic characteristics of parents with and without recent prescription opioid use are presented in Table 3 .
Parents with and without recent prescription opioid use were similar in terms of sex, race, age, and age of biological children. However, a significantly lower percentage of parents with recent prescription opioid use had completed college or more (11.4%) compared with parents without recent prescription opioid use (18.8%), and a significantly higher percentage of parents with recent prescription opioid use had experienced financial hardship in the last 12 months (44.1%) compared with parents without recent prescription opioid use (28.2%).
Substance Use Behaviors
A higher percentage of parents with recent prescription opioid use met the criteria for each substance use behavior compared with parents without recent prescription opioid use (Table 4 ). In particular, a significantly higher percentage of parents with recent use than without recent use met criteria for a lifetime diagnosis of other drug abuse or dependence (14.2% vs 6.7%) and reported misuse of prescription opioids (26.3% vs 11.8%), prescription tranquilizers (16.8% vs 6.6%), and prescription sedatives (16.0% vs 7.1%).
Discussion
In a nationally representative sample of young adults, we examined prescription opioid use among those who were the primary caregivers of children. We found that 6.7% of parents had taken a prescription opioid in the last four weeks, indicating that a substantial number of children are living with parents who use substances with high abuse potential. Contrary to our hypothesis, we found that a significantly higher percentage of parents had recent prescription opioid use compared with nonparents. However, parents did not report a higher prevalence of medical conditions that might explain higher usage of prescription opioids, such as a lifetime diagnosis of cancer, an injury in the last four weeks or last 12 months, or surgery in the last four weeks. In fact, a significantly greater proportion of nonparents reported an injury in the last four weeks or a serious injury in the last 12 months. To examine if prescription medication use in general was greater among parents compared with nonparents, we conducted post hoc analyses and found that parents and nonparents did not differ with respect to the percentage that had taken other types of prescription medications in the last four weeks including benzodiazepines (2.3% vs 2.0%) and antidepressants (6.5% vs 6.9%) or with respect to the average number of prescription medications they had taken in the last four weeks (1.8 vs 1.9 medications). As such, it remains unclear as to why more parents than nonparents had taken a prescription opioid in the last four weeks.
Parents with and without recent prescription opioid use were similar with respect to most demographic characteristics. However, a higher percentage of parents with recent prescription opioid use reported having experienced financial hardship in the last 12 months. This finding is consistent with previous research in the United States that has documented an inverse association between the prevalence of prescription opioid use and annual income [16, 17] . In the present study, there may be contextual factors that contribute to both prescription opioid use and financial hardship. For example, individuals with chronic pain may be unable to work due to their condition, therefore limiting their financial resources. Parents with recent prescription opioid use may also need to devote financial resources to obtaining medications, resulting in decreased resources available for other needs. Importantly, almost half of parents with recent prescription opioid use reported not having enough money to meet basic needs related to shelter, housing, and food in the last 12 months, with potential negative effects on parent and child health and wellbeing.
Parents with and without recent prescription opioid use differed substantially with respect to substance use behaviors. As hypothesized, there was a higher prevalence of lifetime substance abuse or dependence and prescription drug misuse among parents with recent prescription opioid use. While we do not know whether the most recent prescription for an opioid was used appropriately, it is important to note that parents with recent prescription opioid use were more likely to report a history of inappropriate use of substances. Indeed, more than one-fourth of parents with recent prescription opioid use reported having ever misused a prescription opioid. Previous studies have found nonmedical use of prescription opioids to be associated with other substance use disorders [16] , indicating that prescription opioid use may cluster with other adverse substance use behaviors. Such polysubstance use may have important implications for parenting behaviors.
Previous studies provide some insight into the potential implications of prescription opioid use for parenting behaviors [8] [9] [10] , but have several limitations. Many of the prior studies recruited parents from clinical populations receiving treatment for opioid use disorders, and results may not generalize to the larger population of parents using prescription opioids. In addition, the majority of studies examined opioid use broadly and did not differentiate between illicit and prescription opioids. To date, studies specific to prescription opioid use among parents have largely focused on use among pregnant women and associated effects on the mother and fetus. Research extending beyond pregnancy will be important to understanding how prescription opioid use affects parents and children outside of the perinatal period.
Limitations
There are several limitations of the present study. All measures were based on respondent self-report. Some measures may have been recalled inaccurately or may reflect social desirability. While nationally representative, the study data were limited to young adults age 24 to 32 years, and thus we were only able to assess prescription opioid use among young parents. Previous research has noted differences in the use of prescription opioids by age, with those age 20 to 39 years less likely to have taken a prescription opioid in the past 30 days compared with those age 40 to 59 years [2] . As such, the extent of prescription opioid use among parents may be even greater if parents over the age of 32 years were also included.
Data regarding recent prescription opioid use were limited. Participants were asked to provide or report the names of all prescription medications taken within the last four weeks. Information was not collected regarding the indication for the prescription, the strength of the prescription, the dose, or the duration of use. Prescription opioid use within the last four weeks may have been part of a history of regular use or may have represented a unique event. Use of data from states' prescription drug monitoring programs may be useful in future research for obtaining such information. In addition, respondents may have only reported use of medications prescribed specifically to them, or they may have also reported use of medications that had been prescribed for someone else. Such information is particularly relevant to prescription opioid use. Research has found that the majority of nonmedical users of prescription opioids obtain the medication from family or friends rather than through a prescription from a medical provider [18, 19] . Greater detail regarding prescription opioid use would be useful in exploring potential explanations for the differences in use observed between parents and nonparents and for understating the potential implications of use for parenting behaviors. Responses of "don't know" or "refused" are not presented but were included in denominators for calculating percentages. Frequencies are unweighted counts. Percentages are weighted. CI ¼ confidence interval. *One or more biological, adopted, or step-child living in the household. † Use of a prescription opioid in the last four weeks. ‡ No prescription opioid use in the last four weeks.
Data regarding prescription opioid misuse and other substance abuse and dependence were limited to lifetime behaviors. We were unable to assess whether parents were currently engaging in prescription opioid misuse or currently abusing or dependent on other substances. Information regarding parents' lifetime as well as current substance use behaviors may provide important insight into the tangible effects of such behaviors on parent and child health and well-being.
Conclusions
Results from the present study suggest that there is notable prescription opioid use among young parents in the United States. In addition, the results indicate that parents who use prescription opioids may be at particular risk of engaging in misuse or abuse behaviors given the observed association between a history of risky substance use and current prescription opioid use. These results underscore the importance of additional research examining the effect of prescription opioid use on parenting behaviors and functioning and the subsequent implications for children. 
